IFNG and neoplasm: Interleukin-12 is also one of the critical cytokines in anti-tumor defense that can inhibit tumor growth and progression by stimulating Th1 responses and IFN-γ production, increasing the cytotoxic activity of lymphocytes, and inhibiting lymphocytes angiogenesis (92, 117).